Examination of the Phenomenology of the Ibogaine Treatment Experience: Role of Altered States of Consciousness and Psychedelic Experiences

Heink, A., Katsikas, S., & Lange-Altman, T. | Journal of Psychoactive Drugs | 7 March 2017

Intranasal Ketamine and Cognitive-Behavioral Therapy for Treatment-Refractory Obsessive-Compulsive Disorder

Adams, T. G., Bloch, M. H., & Pittenger, C. | Journal of clinical psychopharmacology | 1 March 2017

Psychedelics and the science of self-experience

Nour, M. M., & Carhart-Harris, R. L. | The British Journal of Psychiatry | 1 March 2017

Indole Alkaloids from Plants as Potential Leads for Antidepressant Drugs: A Mini Review

Hamid, H. A., Ramli, A. N., & Yusoff, M. M. | Frontiers in Pharmacology | 28 February 2017

Effects of Hallucinogens on Neuronal Activity

Lladó-Pelfort, L., Celada, P., Riga, M. S., Troyano-Rodríguez, E., Santana, N., & Artigas, F. | Current Topics in Behavioural Neuroscience | 26 February 2017

Ayahuasca dimethyltryptamine, and psychosis: a systematic review of human studies

dos Santos, R. G., Bouso, J. C., & Hallak, J. E. | Therapeutic Advances in Psychopharmacology | 23 February 2017

Safety pharmacology of acute MDMA administration in healthy subjects

Vizeli, P., & Liechti, M. E. | Journal of Psychopharmacology | 21 February 2017

22-azidosalvinorin A exhibits antidepressant-like effect in mice

Fajemiroye, J. O., Prabhakar, P. R., da Cunha, C. L., Costa, E. A., & Zjawiony, J. K. | European Journal of Pharmacology | 17 February 2017

Altered Insula Connectivity Under MDMA

Walpola, I. C., Nest, T., Roseman, L., Erritzoe, D., Feilding, A., Nutt, D. J., & Carhart-Harris, R. L. | Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology | 14 February 2017

Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects

Dolder, P. C., Schmid, Y., Steuer, A. E., Kraemer, T., Rentsch, K. M., Hammann, F., & Liechti, M. E. | Clinical Pharmacokinetics | 14 February 2017

Prophylactic Ketamine Attenuates Learned Fear

McGowan, J. C., LaGamma, C. T., Lim, S. C., Tsitsiklis, M., Neria, Y., Brachman, R. A., & Denny, C. A. | Neuropsychopharmacology | 27 January 2017

Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomised placebo-controlled trial

Palhano-Fontes, F., Barreto, D., Onias, H., Andrade, K. C., Novaes, M., Pessoa, J., ... & Tofoli, L. | bioRxiv | 27 January 2017

The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation

Preller, K. H., Herdener, M., Pokorny, T., Planzer, A., Kraehenmann, R., Stämpfli, P., ... & Vollenweider, F. X. | Current Biology | 26 January 2017

Reply to: Ketamine and Psychosis History: Antidepressant Efficacy and Psychotomimetic Effects Postinfusion

da Frota Ribeiro, C. M., Sanacora, G., & Ostroff, R. | Biological Psychiatry | 23 January 2017

The fibrinolytic system: A new target for treatment of depression with psychedelics

Idell, R. D., Florova, G., Komissarov, A. A., Shetty, S., Girard, R. B. S., & Idell, S. | Medical Hypotheses | 23 January 2017

Administration of ketamine for unipolar and bipolar depression

Kraus, C., Rabl, U., Vanicek, T., Carlberg, L., Popovic, A., Spies, M., ... & Willeit, M. | International Journal of Psychiatry in Clinical Practice | 18 January 2017

Ayahuasca: An ancient sacrament for treatment of contemporary psychiatric illness?

Malcolm, B. J., & Lee, K. C. | Mental Health Clinician | 1 January 2017

Clinical potential of psilocybin as a treatment for mental health conditions

Daniel, J., & Haberman, M. | Mental Health Clinician | 1 January 2017

Treating drug dependence with the aid of ibogaine: A qualitative study

Schenberg, E. E., de Castro Comis, M. A., Alexandre, J. F. M., Chaves, B. D. R., Tófoli, L. F., & da Silveira, D. X. | Journal of Psychedelic Studies | 1 January 2017

Can 3,4,-methylenedioxymethamphetamine therapy be used to treat alcohol use disorder?

Sessa, B. | Journal of Psychedelic Studies | 30 December 2016

The antiaddictive effects of ibogaine: A systematic literature review of human studies

dos Santos, R. G., Bouso, J. C., & Hallak, J. E. | Journal of Psychedelic Studies | 20 December 2016

Conducting PTSD clinical trials on a Schedule I drug: MDMA

Knopf, A. | Alcoholism & Drug Abuse Weekly | 12 December 2016

A One-Dose Psychedelic Fix for Addiction?

Jacobson, R. | Scientific American Mind | 8 December 2016

Psilocybin: promising results in double-blind trials require confirmation by real-world evidence

Breckenridge, A., & Grobbee, D. E. | Journal of psychopharmacology | 6 December 2016

Psilocybin-assisted psychotherapy for dying cancer patients – aiding the final trip

Spiegel, D. | Journal of psychopharmacology | 6 December 2016